GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Godavari Drugs Ltd

Godavari Drugs Ltd Board Meeting on Nov 11, 2026

BOARD ● No Immediate Change LOW RISK
📅 Filed on BSE: 06 Nov 2026, 08:02 PM IST  ·  BSE ID: 7ba2e491-5323-4e42-9db1-da598a862697
View Original BSE Filing (PDF)
💡
In Simple Terms
Godavari Drugs' board will meet next week to approve the company's financial results for the last quarter and half-year.
🤖 AI Summary
  • Godavari Drugs Ltd to consider unaudited financial results for Q2 FY27 on Nov 11, 2026.
  • Board meeting will also review financial performance for the half year ended September 30, 2026.
  • Company has a closed trading window for designated persons until results declaration.
  • Disclosure adheres to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
🏢 How This Affects the Company
💰
Financial Impact
The approval and subsequent disclosure of financial results will provide clarity on the company's recent performance.
⚠️
Risk Impact
Adherence to SEBI regulations for timely disclosure of financial information mitigates regulatory non-compliance risk.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time. Investors should await the announced financial results.
👤
Who Is Affected
All shareholders are affected by the disclosure of financial results, which provide information on company performance.
🔍
Management Signal
Management is adhering to regulatory timelines for financial reporting, signaling commitment to transparency.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Unaudited financial results for Q2 FY27 announcement on Nov 11, 2026.
Disclosure of financial performance for the half year ended September 30, 2026.
End of trading window closure period as per insider trading code.
LOW RISK Filing is a routine board meeting intimation for financial results.
💡 Investor Takeaway
Godavari Drugs Ltd has scheduled a board meeting for November 11, 2026, to approve unaudited financial results for the quarter and half year ended September 30, 2026. Trading window remains closed.
❓ Frequently Asked Questions
When is Godavari Drugs Ltd holding its Board Meeting?
Godavari Drugs Ltd is holding its Board of Directors meeting on November 11, 2026.
What is the agenda for the Godavari Drugs Ltd Board Meeting on November 11, 2026?
The Board meeting is scheduled to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026.
When will the trading window for Godavari Drugs Ltd securities reopen?
The trading window will remain closed until 48 hours after the declaration of the unaudited financial results for the quarter and half year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.